Cramer Pamela J. sold RYTM
December 11, 2025 · Form 4 insider transaction
Cramer Pamela J. sold 3,350 shares of Rhythm Pharmaceuticals, Inc. at $111.00 per share, a transaction worth $371.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,350
Price
$111.00
Total value
$371.9K
InsiderCramer Pamela J.
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 11, 2025
Filing dateDecember 15, 2025
Shares owned after20,814
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2025.